Berek J S, Hacker N F, Fu Y S, Sokale J R, Leuchter R C, Lagasse L D
Obstet Gynecol. 1985 Jan;65(1):46-52.
One hundred and two patients were treated for primary adenocarcinoma of the uterine cervix over a ten-year period from 1973 to 1982. Of these, 51 patients underwent initial surgical management that included a pelvic and para-aortic lymphadenectomy with a radical hysterectomy or a surgical staging operation. Clinical lesion size, grade, and depth of stromal invasion were correlated with lymph node metastasis and survival. The incidence of positive lymph nodes was 14.6% for stage I and 40.0% for stage II. Positive lymph nodes were documented in none of 15 patients with lesions smaller than 2 cm, 16.7% (five of 30) with 2 to 4 cm, and 82.3% (five of six) with larger than 4 cm; 5.3% of grade 1 tumors, 11.1% of grade 2, and 50.0% of grade 3. There were no lymph node metastases (zero of six) in patients with a tumor that had a depth invasion of less than 2 mm, whereas positive nodes were found in 11.1% (two of 18) patients with 2 to 5 mm of invasion, 28.6% (two of seven) with 5 to 10 mm, and 57.1% (four of seven) with greater than 10 mm of invasion. Five-year survival was 82.9% for stage I and 42.9% for stage II patients; 91.7% with negative lymph nodes, and 10% with positive nodes (P less than .0001). The size of the primary tumor (P less than .0001), tumor grade (P less than .05), and depth of invasion (P less than .05) correlated with patient survival.(ABSTRACT TRUNCATED AT 250 WORDS)
1973年至1982年的十年间,102例患者接受了子宫颈原发性腺癌的治疗。其中,51例患者接受了初始手术治疗,包括盆腔和腹主动脉旁淋巴结清扫术以及根治性子宫切除术或手术分期手术。临床病变大小、分级和间质浸润深度与淋巴结转移及生存率相关。I期患者淋巴结阳性率为14.6%,II期为40.0%。15例病变小于2 cm的患者中无一例有淋巴结阳性记录;2至4 cm的患者中16.7%(30例中的5例)有阳性记录;大于4 cm的患者中82.3%(6例中的5例)有阳性记录;1级肿瘤患者中5.3%有阳性记录,2级为11.1%,3级为50.0%。肿瘤浸润深度小于2 mm的患者无淋巴结转移(6例中的0例),而浸润深度为2至5 mm的患者中11.1%(18例中的2例)有阳性淋巴结,5至10 mm的患者中28.6%(7例中的2例)有阳性淋巴结,大于10 mm的患者中57.1%(7例中的4例)有阳性淋巴结。I期患者的五年生存率为82.9%,II期患者为42.9%;淋巴结阴性患者为91.7%,阳性患者为10%(P小于0.0001)。原发肿瘤大小(P小于0.0001)、肿瘤分级(P小于0.05)和浸润深度(P小于0.05)与患者生存率相关。(摘要截选至250字)